speb/financial-data huggingface dataset:
MED income_statement (annual, 2025-12-31) — Operating Income: -14213000.00
MED income_statement (quarterly, 2025-12-31) — Operating Income: -7803000.00
MED income_statement (annual, 2025-12-31) — Operating Revenue: 385788000.00
MED income_statement (quarterly, 2025-12-31) — Operating Revenue: 75096000.00
MED balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 10991273.00
MED balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 10991273.00
MED balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 234000.00
MED balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 234000.00
MED income_statement (annual, 2025-12-31) — Other Income Expense: 3058000.00
MED income_statement (quarterly, 2025-12-31) — Other Income Expense: 1000.00
MED balance_sheet (annual, 2025-12-31) — Other Inventories: 1654000.00
MED balance_sheet (quarterly, 2025-12-31) — Other Inventories: 1654000.00
MED cash_flow (annual, 2025-12-31) — Other Non Cash Items: 4624000.00
MED cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1165000.00
MED balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 7828000.00
MED balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 7828000.00
MED income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 3058000.00
MED income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1000.00
MED balance_sheet (annual, 2025-12-31) — Other Payable: 6727000.00
MED balance_sheet (quarterly, 2025-12-31) — Other Payable: 6727000.00
MED balance_sheet (annual, 2025-12-31) — Other Properties: 7232000.00
MED balance_sheet (quarterly, 2025-12-31) — Other Properties: 7232000.00
MED balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 77970000.00
MED balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 77970000.00
MED balance_sheet (annual, 2025-12-31) — Payables: 29272000.00
MED balance_sheet (quarterly, 2025-12-31) — Payables: 29272000.00
MED balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 37975000.00
MED balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 37975000.00
MED balance_sheet (annual, 2025-12-31) — Prepaid Assets: 14182000.00
MED balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 14182000.00
MED income_statement (annual, 2025-12-31) — Pretax Income: -5639000.00
MED income_statement (quarterly, 2025-12-31) — Pretax Income: -6382000.00
MED cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
MED cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
MED balance_sheet (annual, 2025-12-31) — Properties: 0.00
MED balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MED cash_flow (annual, 2025-12-31) — Purchase Of Investment: -84407000.00
MED cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -32912000.00
MED cash_flow (annual, 2025-12-31) — Purchase Of PPE: -5614000.00
MED cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1351000.00
MED balance_sheet (annual, 2025-12-31) — Raw Materials: 4915000.00
MED balance_sheet (quarterly, 2025-12-31) — Raw Materials: 4915000.00
MED income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 110601000.00
MED income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 22956000.00
MED income_statement (annual, 2025-12-31) — Reconciled Depreciation: 14242000.00
MED income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3465000.00
MED cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -369000.00
MED cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 1000.00
MED balance_sheet (annual, 2025-12-31) — Retained Earnings: 158269000.00
MED balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 158269000.00
MED cash_flow (annual, 2025-12-31) — Sale Of Investment: 82093000.00
MED cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 29313000.00
MED income_statement (annual, 2025-12-31) — Selling General And Administration: 289400000.00
MED income_statement (quarterly, 2025-12-31) — Selling General And Administration: 59943000.00
MED balance_sheet (annual, 2025-12-31) — Share Issued: 10991273.00
MED balance_sheet (quarterly, 2025-12-31) — Share Issued: 10991273.00
MED cash_flow (annual, 2025-12-31) — Stock Based Compensation: 7639000.00
MED cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2172000.00
MED balance_sheet (annual, 2025-12-31) — Stockholders Equity: 198920000.00
MED balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 198920000.00
MED balance_sheet (annual, 2025-12-31) — Tangible Book Value: 198920000.00
MED balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 198920000.00
MED income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MED income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MED income_statement (annual, 2025-12-31) — Tax Provision: 13033000.00
MED income_statement (quarterly, 2025-12-31) — Tax Provision: 11737000.00
MED income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
MED income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
MED balance_sheet (annual, 2025-12-31) — Total Assets: 247973000.00
MED balance_sheet (quarterly, 2025-12-31) — Total Assets: 247973000.00
MED balance_sheet (annual, 2025-12-31) — Total Capitalization: 198920000.00
MED balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 198920000.00
MED balance_sheet (annual, 2025-12-31) — Total Debt: 10694000.00
MED balance_sheet (quarterly, 2025-12-31) — Total Debt: 10694000.00
MED balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 198920000.00
MED balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 198920000.00
MED income_statement (annual, 2025-12-31) — Total Expenses: 400001000.00
MED income_statement (quarterly, 2025-12-31) — Total Expenses: 82899000.00
MED balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 49053000.00
MED balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 49053000.00
MED balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 46290000.00
MED balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 46290000.00
MED balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6091000.00
MED balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6091000.00
MED income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -14213000.00
MED income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -7803000.00
MED balance_sheet (annual, 2025-12-31) — Total Tax Payable: 7184000.00
MED balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 7184000.00
MED cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -17000.00
MED cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -3000.00
MED balance_sheet (annual, 2025-12-31) — Working Capital: 158721000.00
MED balance_sheet (quarterly, 2025-12-31) — Working Capital: 158721000.00
MED income_statement (quarterly, 2026-03-31) — +Operating Expense: 55051000.00
MED income_statement (quarterly, 2026-03-31) — +Total Revenue: 76044000.00
MED balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 38264000.00
MED balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 41488000.00
MED cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -164000.00
MED income_statement (quarterly, 2026-03-31) — Basic Average Shares: 11006000.00
MED income_statement (quarterly, 2026-03-31) — Basic EPS: -0.19
MED cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 89303000.00
MED cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1096000.00
MED balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 16101000.00
MED balance_sheet (quarterly, 2026-03-31) — Capital Stock: 11000.00
MED balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 71529000.00
MED balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 168946000.00
MED cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -87000.00
MED cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -901000.00
MED cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -17133000.00
MED cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 260000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -1449000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: -200000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Inventory: -1175000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 262000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Payable: -1649000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1649000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 649000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: -200000.00
MED cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1913000.00
MED cash_flow (quarterly, 2026-03-31) — Changes In Cash: -17774000.00
MED balance_sheet (quarterly, 2026-03-31) — Common Stock: 11000.00
MED cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -87000.00
MED balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 197681000.00
MED cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -814000.00
MED income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 24288000.00
MED balance_sheet (quarterly, 2026-03-31) — Current Assets: 202630000.00
MED balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3920000.00
MED balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3920000.00
MED balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 42184000.00
MED cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 0.00
MED cash_flow (quarterly, 2026-03-31) — Deferred Tax: 0.00
MED cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3483000.00
MED cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3483000.00
MED income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 11006000.00
MED income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.19
MED income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -2122000.00
MED income_statement (quarterly, 2026-03-31) — EBIT: -3295000.00
MED income_statement (quarterly, 2026-03-31) — EBITDA: 188000.00
MED cash_flow (quarterly, 2026-03-31) — End Cash Position: 71529000.00
MED cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -901000.00
MED balance_sheet (quarterly, 2026-03-31) — Finished Goods: 17511000.00
MED cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -836000.00
MED cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -2209000.00
MED cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 63000.00
MED balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 33000.00
MED balance_sheet (quarterly, 2026-03-31) — Gross PPE: 42564000.00
MED income_statement (quarterly, 2026-03-31) — Gross Profit: 51756000.00
MED cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 241000.00
MED income_statement (quarterly, 2026-03-31) — Interest Income: 1379000.00
MED income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1379000.00
MED balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -3741000.00
MED balance_sheet (quarterly, 2026-03-31) — Inventory: 21403000.00
MED balance_sheet (quarterly, 2026-03-31) — Invested Capital: 197681000.00
MED cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -17133000.00
MED balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 12181000.00
MED balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12181000.00
MED cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -814000.00
MED income_statement (quarterly, 2026-03-31) — Net Income: -2122000.00
MED income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -2122000.00
MED income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -2122000.00
MED income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -2122000.00
MED income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -2122000.00
MED cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -2122000.00
MED income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -2122000.00
MED income_statement (quarterly, 2026-03-31) — Net Interest Income: 1379000.00
MED cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -19674000.00
MED income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1379000.00
MED cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 3637000.00
MED balance_sheet (quarterly, 2026-03-31) — Net PPE: 42564000.00
MED cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1096000.00
MED balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 197681000.00
MED income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 188000.00
MED income_statement (quarterly, 2026-03-31) — Normalized Income: -2122000.00
MED cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 260000.00
MED cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2146000.00
MED income_statement (quarterly, 2026-03-31) — Operating Income: -3295000.00
MED income_statement (quarterly, 2026-03-31) — Operating Revenue: 76044000.00
MED balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 11119000.00
MED balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 33000.00
MED income_statement (quarterly, 2026-03-31) — Other Income Expense: -25000.00
MED balance_sheet (quarterly, 2026-03-31) — Other Inventories: 1160000.00
MED cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1160000.00
MED balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 6852000.00
MED income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -25000.00
MED balance_sheet (quarterly, 2026-03-31) — Other Properties: 42564000.00
MED balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 97417000.00
MED balance_sheet (quarterly, 2026-03-31) — Payables: 38264000.00
MED balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 38264000.00
MED balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 12281000.00
MED income_statement (quarterly, 2026-03-31) — Pretax Income: -1941000.00
MED cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -49320000.00
MED cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1096000.00
MED balance_sheet (quarterly, 2026-03-31) — Raw Materials: 6473000.00
MED income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 24288000.00
MED income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3483000.00
MED cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -814000.00
MED balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 156149000.00
MED cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 29646000.00
MED income_statement (quarterly, 2026-03-31) — Selling General And Administration: 55051000.00
MED balance_sheet (quarterly, 2026-03-31) — Share Issued: 11119000.00
MED cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1896000.00
MED balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 197681000.00
MED balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 197681000.00
MED income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MED income_statement (quarterly, 2026-03-31) — Tax Provision: 181000.00
MED income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
MED balance_sheet (quarterly, 2026-03-31) — Total Assets: 252046000.00
MED balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 197681000.00
MED balance_sheet (quarterly, 2026-03-31) — Total Debt: 16101000.00
MED balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 197681000.00
MED income_statement (quarterly, 2026-03-31) — Total Expenses: 79339000.00
MED balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 54365000.00
MED balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 49416000.00
MED balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 12181000.00
MED income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -3295000.00
MED cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 66000.00
MED balance_sheet (quarterly, 2026-03-31) — Working Capital: 160446000.00
MED.DE income_statement (annual, 2021-12-31) — +Operating Expense: 540104492.00
MED.DE income_statement (annual, 2021-12-31) — +Total Revenue: 673100000.00
MED.DE balance_sheet (annual, 2021-12-31) — Accounts Payable: 14842889.00
MED.DE balance_sheet (annual, 2021-12-31) — Accounts Receivable: 81213964.00
MED.DE balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -478519000.00
MED.DE balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -2894000.00
MED.DE income_statement (annual, 2021-12-31) — Amortization: 3100000.00
MED.DE balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 10270953.00
MED.DE balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 782590.00
MED.DE income_statement (annual, 2021-12-31) — Basic Average Shares: 47500000.00
MED.DE income_statement (annual, 2021-12-31) — Basic EPS: 0.03
MED.DE cash_flow (annual, 2021-12-31) — Beginning Cash Position: 100437077.00
MED.DE balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 460175000.00
MED.DE cash_flow (annual, 2021-12-31) — Capital Expenditure: -17005831.00
MED.DE balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 343778694.00
MED.DE balance_sheet (annual, 2021-12-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 119516458.00
MED.DE balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 119516458.00
MED.DE cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -25715421.00
MED.DE cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: 31746934.00
MED.DE cash_flow (annual, 2021-12-31) — Change In Working Capital: 1729419.00
MED.DE cash_flow (annual, 2021-12-31) — Changes In Cash: 19615293.00
MED.DE balance_sheet (annual, 2021-12-31) — Common Stock: 47500000.00
MED.DE balance_sheet (annual, 2021-12-31) — Common Stock Equity: 183278420.00
MED.DE balance_sheet (annual, 2021-12-31) — Construction In Progress: 7330000.00
MED.DE income_statement (annual, 2021-12-31) — Cost Of Revenue: 122100000.00
MED.DE balance_sheet (annual, 2021-12-31) — Current Assets: 265933476.00
MED.DE balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 54935803.00
MED.DE balance_sheet (annual, 2021-12-31) — Current Debt: 26839164.00
MED.DE balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 81774967.00
MED.DE balance_sheet (annual, 2021-12-31) — Current Liabilities: 213407158.00
MED.DE balance_sheet (annual, 2021-12-31) — Current Provisions: 13529707.00
MED.DE cash_flow (annual, 2021-12-31) — Deferred Tax: 960961.00
MED.DE cash_flow (annual, 2021-12-31) — Depreciation: 73658672.00
MED.DE cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 73658672.00
MED.DE income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 73600000.00
MED.DE income_statement (annual, 2021-12-31) — Depreciation Income Statement: 70500000.00
MED.DE income_statement (annual, 2021-12-31) — Diluted Average Shares: 47500000.00
MED.DE income_statement (annual, 2021-12-31) — Diluted EPS: 0.03
MED.DE income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: 1461436.00
MED.DE income_statement (annual, 2021-12-31) — EBIT: 11771246.00
MED.DE income_statement (annual, 2021-12-31) — EBITDA: 85429918.00
MED.DE cash_flow (annual, 2021-12-31) — End Cash Position: 120052370.00
MED.DE cash_flow (annual, 2021-12-31) — Financing Cash Flow: -55260717.00
MED.DE cash_flow (annual, 2021-12-31) — Free Cash Flow: 64960857.00
MED.DE cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -89473.00
MED.DE income_statement (annual, 2021-12-31) — General And Administrative Expense: 8700000.00
MED.DE balance_sheet (annual, 2021-12-31) — Goodwill: 49869000.00
MED.DE balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 56938015.00
MED.DE balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 84108000.00
MED.DE balance_sheet (annual, 2021-12-31) — Gross PPE: 986779000.00
MED.DE income_statement (annual, 2021-12-31) — Gross Profit: 551000000.00
MED.DE income_statement (annual, 2021-12-31) — Interest Expense: 9325000.00
MED.DE income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 9325000.00
MED.DE income_statement (annual, 2021-12-31) — Interest Income: 48000.00
MED.DE income_statement (annual, 2021-12-31) — Interest Income Non Operating: 48000.00
MED.DE cash_flow (annual, 2021-12-31) — Interest Paid Cff: -8295350.00
MED.DE cash_flow (annual, 2021-12-31) — Interest Received Cfo: 44505.00
MED.DE balance_sheet (annual, 2021-12-31) — Inventory: 8514754.00
MED.DE balance_sheet (annual, 2021-12-31) — Invested Capital: 279459135.00
MED.DE cash_flow (annual, 2021-12-31) — Investing Cash Flow: -7090678.00
MED.DE balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 782590.00
MED.DE balance_sheet (annual, 2021-12-31) — Investmentsin Subsidiariesat Cost: 64822.00
MED.DE balance_sheet (annual, 2021-12-31) — Land And Improvements: 298517000.00
MED.DE balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 288842891.00
MED.DE balance_sheet (annual, 2021-12-31) — Long Term Debt: 69341551.00
MED.DE balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 358184442.00
MED.DE cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -1965656.00
MED.DE balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 64822.00
MED.DE balance_sheet (annual, 2021-12-31) — Long Term Provisions: 23762567.00
MED.DE balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 220757000.00
MED.DE balance_sheet (annual, 2021-12-31) — Minority Interest: -254927.00
MED.DE income_statement (annual, 2021-12-31) — Minority Interests: -23849.00
MED.DE cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 9610302.00
MED.DE income_statement (annual, 2021-12-31) — Net Income: 1461436.00
MED.DE income_statement (annual, 2021-12-31) — Net Income Common Stockholders: 1461436.00
MED.DE income_statement (annual, 2021-12-31) — Net Income Continuous Operations: 1485285.00
MED.DE income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: 1461436.00
MED.DE income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: 1461436.00
MED.DE cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: 1485285.00
MED.DE income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: 1485285.00
MED.DE cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -1775258.00
MED.DE income_statement (annual, 2021-12-31) — Net Interest Income: -9277000.00
MED.DE cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -38375.00
MED.DE cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -1965656.00
MED.DE cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -1965656.00
MED.DE income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: -9277000.00
MED.DE cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -1965656.00
MED.DE cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 51000.00
MED.DE balance_sheet (annual, 2021-12-31) — Net PPE: 508260000.00
MED.DE cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -14938347.00
MED.DE balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 126340405.00
MED.DE balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 10656318.00
MED.DE balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 61358730.00
MED.DE income_statement (annual, 2021-12-31) — Normalized EBITDA: 85429918.00
MED.DE income_statement (annual, 2021-12-31) — Normalized Income: 1461436.00
MED.DE cash_flow (annual, 2021-12-31) — Operating Cash Flow: 81966688.00
MED.DE income_statement (annual, 2021-12-31) — Operating Income: 10895508.00
MED.DE income_statement (annual, 2021-12-31) — Operating Revenue: 673100000.00
MED.DE balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Current Assets: 500.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 18499048.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 7069015.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Inventories: -246.00
MED.DE cash_flow (annual, 2021-12-31) — Other Non Cash Items: 6547410.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 179.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 39531540.00
MED.DE income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 700000.00
MED.DE income_statement (annual, 2021-12-31) — Other Operating Expenses: 44000000.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Payable: 227000.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Properties: 220757000.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Receivables: 41503200.00
MED.DE balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 13967132.00
MED.DE income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (annual, 2021-12-31) — Payables: 20254889.00
MED.DE balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 64181000.00
MED.DE balance_sheet (annual, 2021-12-31) — Prepaid Assets: 1627177.00
MED.DE income_statement (annual, 2021-12-31) — Pretax Income: 2446246.00
MED.DE balance_sheet (annual, 2021-12-31) — Properties: 0.00
MED.DE cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -1775258.00
MED.DE cash_flow (annual, 2021-12-31) — Purchase Of Investment: -38375.00
MED.DE cash_flow (annual, 2021-12-31) — Purchase Of PPE: -15230573.00
MED.DE balance_sheet (annual, 2021-12-31) — Raw Materials: 8515000.00
MED.DE income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 122100000.00
MED.DE income_statement (annual, 2021-12-31) — Reconciled Depreciation: 73658672.00
MED.DE income_statement (annual, 2021-12-31) — Rent And Landing Fees: 3500000.00
MED.DE income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 3500000.00
MED.DE cash_flow (annual, 2021-12-31) — Repayment Of Debt: -1965656.00
MED.DE balance_sheet (annual, 2021-12-31) — Retained Earnings: 6386591.00
MED.DE cash_flow (annual, 2021-12-31) — Sale Of Business: 9610302.00
MED.DE cash_flow (annual, 2021-12-31) — Sale Of PPE: 292226.00
MED.DE income_statement (annual, 2021-12-31) — Selling General And Administration: 8700000.00
MED.DE balance_sheet (annual, 2021-12-31) — Share Issued: 47500000.00
MED.DE balance_sheet (annual, 2021-12-31) — Stockholders Equity: 183278420.00
MED.DE balance_sheet (annual, 2021-12-31) — Tangible Book Value: 126340405.00
MED.DE income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (annual, 2021-12-31) — Tax Provision: 960961.00
MED.DE income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.39
MED.DE balance_sheet (annual, 2021-12-31) — Taxes Receivable: 3286470.00
MED.DE cash_flow (annual, 2021-12-31) — Taxes Refund Paid: -2370091.00
MED.DE balance_sheet (annual, 2021-12-31) — Total Assets: 881238930.00
MED.DE balance_sheet (annual, 2021-12-31) — Total Capitalization: 252619971.00
MED.DE balance_sheet (annual, 2021-12-31) — Total Debt: 439959409.00
MED.DE balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 183023493.00
MED.DE income_statement (annual, 2021-12-31) — Total Expenses: 662204492.00
MED.DE balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 698215437.00
MED.DE balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 615305454.00
MED.DE balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 484808279.00
MED.DE income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 11563113.00
MED.DE balance_sheet (annual, 2021-12-31) — Total Tax Payable: 5185000.00
MED.DE balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 1971000.00
MED.DE balance_sheet (annual, 2021-12-31) — Working Capital: 52526318.00
MED.DE income_statement (annual, 2022-12-31) — +Operating Expense: 553428171.00
MED.DE income_statement (annual, 2022-12-31) — +Total Revenue: 704700000.00
MED.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 14506203.00
MED.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 88489268.00
MED.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -539249000.00
MED.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -3572000.00
MED.DE income_statement (annual, 2022-12-31) — Amortization: 2900000.00
MED.DE balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 13615035.00
MED.DE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 722769.00
MED.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 47500000.00
MED.DE income_statement (annual, 2022-12-31) — Basic EPS: 0.20
MED.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 120052370.00
MED.DE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 543610000.00
MED.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -26018598.00
MED.DE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 408358333.00
MED.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 88039485.00
MED.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 88039485.00
MED.DE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -27355508.00
MED.DE cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -18955954.00
MED.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: -49495345.00
MED.DE cash_flow (annual, 2022-12-31) — Changes In Cash: -27774901.00
MED.DE balance_sheet (annual, 2022-12-31) — Common Stock: 47500000.00
MED.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 209206824.00
MED.DE balance_sheet (annual, 2022-12-31) — Construction In Progress: 12793000.00
MED.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 132900000.00
MED.DE balance_sheet (annual, 2022-12-31) — Current Assets: 262008270.00
MED.DE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 23410612.00
MED.DE balance_sheet (annual, 2022-12-31) — Current Debt: 26770232.00
MED.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 50180844.00
MED.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 170843103.00
MED.DE balance_sheet (annual, 2022-12-31) — Current Provisions: 12605537.00
MED.DE cash_flow (annual, 2022-12-31) — Deferred Tax: 58063.00
MED.DE cash_flow (annual, 2022-12-31) — Depreciation: 71404145.00
MED.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 71404145.00
MED.DE income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 71400000.00
MED.DE income_statement (annual, 2022-12-31) — Depreciation Income Statement: 68500000.00
MED.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 47500000.00
MED.DE income_statement (annual, 2022-12-31) — Diluted EPS: 0.20
MED.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 9440631.00
MED.DE income_statement (annual, 2022-12-31) — EBIT: 20400031.00
MED.DE income_statement (annual, 2022-12-31) — EBITDA: 91804176.00
MED.DE cash_flow (annual, 2022-12-31) — End Cash Position: 92277469.00
MED.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -56171852.00
MED.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 8620899.00
MED.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -240925.00
MED.DE income_statement (annual, 2022-12-31) — General And Administrative Expense: 15600000.00
MED.DE balance_sheet (annual, 2022-12-31) — Goodwill: 49869000.00
MED.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 55534762.00
MED.DE balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 92061000.00
MED.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 1083188000.00
MED.DE income_statement (annual, 2022-12-31) — Gross Profit: 571800000.00
MED.DE income_statement (annual, 2022-12-31) — Interest Expense: 10623000.00
MED.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 10623000.00
MED.DE income_statement (annual, 2022-12-31) — Interest Income: 881000.00
MED.DE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 881000.00
MED.DE cash_flow (annual, 2022-12-31) — Interest Paid Cff: -10068816.00
MED.DE cash_flow (annual, 2022-12-31) — Interest Received Cfo: 718009.00
MED.DE balance_sheet (annual, 2022-12-31) — Inventory: 8869473.00
MED.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 303519490.00
MED.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -6242546.00
MED.DE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 722769.00
MED.DE balance_sheet (annual, 2022-12-31) — Investmentsin Subsidiariesat Cost: 64822.00
MED.DE balance_sheet (annual, 2022-12-31) — Land And Improvements: 301479000.00
MED.DE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 384947721.00
MED.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 67542434.00
MED.DE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 452490155.00
MED.DE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 64822.00
MED.DE balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2451304.00
MED.DE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 225306000.00
MED.DE balance_sheet (annual, 2022-12-31) — Minority Interest: 115976.00
MED.DE income_statement (annual, 2022-12-31) — Minority Interests: -278337.00
MED.DE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
MED.DE balance_sheet (annual, 2022-12-31) — Net Debt: 6273181.00
MED.DE income_statement (annual, 2022-12-31) — Net Income: 9440631.00
MED.DE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 9440631.00
MED.DE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 9718968.00
MED.DE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 9440631.00
MED.DE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 9440631.00
MED.DE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 9718968.00
MED.DE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 9718968.00
MED.DE cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1648017.00
MED.DE income_statement (annual, 2022-12-31) — Net Interest Income: -9742000.00
MED.DE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -42087.00
MED.DE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -9742000.00
MED.DE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1873654.00
MED.DE cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 19144444.00
MED.DE balance_sheet (annual, 2022-12-31) — Net PPE: 543939000.00
MED.DE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -23696886.00
MED.DE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 153672062.00
MED.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 10487180.00
MED.DE balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 40228069.00
MED.DE income_statement (annual, 2022-12-31) — Normalized EBITDA: 91804176.00
MED.DE income_statement (annual, 2022-12-31) — Normalized Income: 9440631.00
MED.DE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 34639497.00
MED.DE income_statement (annual, 2022-12-31) — Operating Income: 18371829.00
MED.DE income_statement (annual, 2022-12-31) — Operating Revenue: 704700000.00
MED.DE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Current Assets: -396.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 317.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 5665762.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Inventories: 473.00
MED.DE cash_flow (annual, 2022-12-31) — Other Non Cash Items: 5718872.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Non Current Assets: -162.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 40776540.00
MED.DE income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1000000.00
MED.DE income_statement (annual, 2022-12-31) — Other Operating Expenses: 40100000.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Payable: 28006814.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Properties: 225306000.00
MED.DE balance_sheet (annual, 2022-12-31) — Other Receivables: 60131941.00
MED.DE income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (annual, 2022-12-31) — Payables: 47449017.00
MED.DE balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 47929000.00
MED.DE balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1462951.00
MED.DE income_statement (annual, 2022-12-31) — Pretax Income: 9777031.00
MED.DE balance_sheet (annual, 2022-12-31) — Properties: 0.00
MED.DE cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1648017.00
MED.DE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -42087.00
MED.DE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -24370581.00
MED.DE balance_sheet (annual, 2022-12-31) — Raw Materials: 8869000.00
MED.DE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 132900000.00
MED.DE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 71404145.00
MED.DE income_statement (annual, 2022-12-31) — Rent And Landing Fees: 3400000.00
MED.DE income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 3400000.00
MED.DE balance_sheet (annual, 2022-12-31) — Retained Earnings: -5591162.00
MED.DE cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
MED.DE cash_flow (annual, 2022-12-31) — Sale Of PPE: 673695.00
MED.DE income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 3200000.00
MED.DE income_statement (annual, 2022-12-31) — Selling General And Administration: 18800000.00
MED.DE balance_sheet (annual, 2022-12-31) — Share Issued: 47500000.00
MED.DE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 209206824.00
MED.DE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 153672062.00
MED.DE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (annual, 2022-12-31) — Tax Provision: 58063.00
MED.DE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.01
MED.DE balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1400513.00
MED.DE cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -3242290.00
MED.DE balance_sheet (annual, 2022-12-31) — Total Assets: 916111971.00
MED.DE balance_sheet (annual, 2022-12-31) — Total Capitalization: 276749258.00
MED.DE balance_sheet (annual, 2022-12-31) — Total Debt: 502670999.00
MED.DE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 209322800.00
MED.DE income_statement (annual, 2022-12-31) — Total Expenses: 686328171.00
MED.DE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 706789171.00
MED.DE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 654103701.00
MED.DE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 535946068.00
MED.DE income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 19519620.00
MED.DE balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4936000.00
MED.DE balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 40776540.00
MED.DE balance_sheet (annual, 2022-12-31) — Working Capital: 91165167.00
MED.DE income_statement (annual, 2023-12-31) — +Operating Expense: 582903833.00
MED.DE income_statement (annual, 2023-12-31) — +Total Revenue: 730100000.00
MED.DE balance_sheet (annual, 2023-12-31) — Accounts Payable: 16210311.00
MED.DE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 81581141.00
MED.DE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -560493000.00
MED.DE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -3775000.00
MED.DE income_statement (annual, 2023-12-31) — Amortization: 36000000.00
MED.DE balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 21347327.00
MED.DE balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 716149.00
MED.DE income_statement (annual, 2023-12-31) — Basic Average Shares: 47500000.00
MED.DE income_statement (annual, 2023-12-31) — Basic EPS: -0.23
MED.DE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 92277469.00
MED.DE balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 542831000.00
MED.DE cash_flow (annual, 2023-12-31) — Capital Expenditure: -37576237.00
MED.DE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 386443214.00
MED.DE balance_sheet (annual, 2023-12-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 115285902.00
MED.DE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 115285902.00
MED.DE cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -20993104.00
MED.DE cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -2594081.00
MED.DE cash_flow (annual, 2023-12-31) — Change In Working Capital: -25310778.00
MED.DE cash_flow (annual, 2023-12-31) — Changes In Cash: 23011211.00
MED.DE balance_sheet (annual, 2023-12-31) — Common Stock: 47500000.00
MED.DE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 195917976.00
MED.DE balance_sheet (annual, 2023-12-31) — Construction In Progress: 25638000.00
MED.DE income_statement (annual, 2023-12-31) — Cost Of Revenue: 135500000.00
MED.DE balance_sheet (annual, 2023-12-31) — Current Assets: 299826743.00
MED.DE balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 23999770.00
MED.DE balance_sheet (annual, 2023-12-31) — Current Debt: 1962376.00
MED.DE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 25962146.00
MED.DE balance_sheet (annual, 2023-12-31) — Current Liabilities: 146239060.00
MED.DE balance_sheet (annual, 2023-12-31) — Current Provisions: 12338610.00
MED.DE cash_flow (annual, 2023-12-31) — Deferred Tax: 2035123.00
MED.DE cash_flow (annual, 2023-12-31) — Depreciation: 86005243.00
MED.DE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 86005243.00
MED.DE income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 86000000.00
MED.DE income_statement (annual, 2023-12-31) — Depreciation Income Statement: 50000000.00
MED.DE income_statement (annual, 2023-12-31) — Diluted Average Shares: 47500000.00
MED.DE income_statement (annual, 2023-12-31) — Diluted EPS: -0.23
MED.DE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -10776122.00
MED.DE income_statement (annual, 2023-12-31) — EBIT: 15260018.00
MED.DE income_statement (annual, 2023-12-31) — EBITDA: 101265261.00
MED.DE cash_flow (annual, 2023-12-31) — End Cash Position: 115288680.00
MED.DE cash_flow (annual, 2023-12-31) — Financing Cash Flow: -45479067.00
MED.DE cash_flow (annual, 2023-12-31) — Free Cash Flow: 40425085.00
MED.DE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -47522.00
MED.DE income_statement (annual, 2023-12-31) — General And Administrative Expense: 14700000.00
MED.DE balance_sheet (annual, 2023-12-31) — Goodwill: 16685000.00
MED.DE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 22800127.00
MED.DE balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 85356000.00
MED.DE balance_sheet (annual, 2023-12-31) — Gross PPE: 1074870000.00
MED.DE income_statement (annual, 2023-12-31) — Gross Profit: 594600000.00
MED.DE income_statement (annual, 2023-12-31) — Interest Expense: 23948875.00
MED.DE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 23948875.00
MED.DE income_statement (annual, 2023-12-31) — Interest Income: 2538243.00
MED.DE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2538243.00
MED.DE cash_flow (annual, 2023-12-31) — Interest Paid Cff: -21829063.00
MED.DE cash_flow (annual, 2023-12-31) — Interest Received Cfo: 2530587.00
MED.DE balance_sheet (annual, 2023-12-31) — Inventory: 7296364.00
MED.DE balance_sheet (annual, 2023-12-31) — Invested Capital: 289299174.00
MED.DE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -9511044.00
MED.DE balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 716149.00
MED.DE balance_sheet (annual, 2023-12-31) — Investmentsin Subsidiariesat Cost: 64822.00
MED.DE balance_sheet (annual, 2023-12-31) — Land And Improvements: 283226000.00
MED.DE balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 362443444.00
MED.DE balance_sheet (annual, 2023-12-31) — Long Term Debt: 91418822.00
MED.DE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 453862266.00
MED.DE balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 64822.00
MED.DE balance_sheet (annual, 2023-12-31) — Long Term Provisions: 2233213.00
MED.DE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 223175000.00
MED.DE balance_sheet (annual, 2023-12-31) — Minority Interest: 111421.00
MED.DE income_statement (annual, 2023-12-31) — Minority Interests: -52142.00
MED.DE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 8648295.00
MED.DE income_statement (annual, 2023-12-31) — Net Income: -10776122.00
MED.DE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -10776122.00
MED.DE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -10723980.00
MED.DE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -10776122.00
MED.DE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -10776122.00
MED.DE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -10723980.00
MED.DE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -10723980.00
MED.DE cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -3157562.00
MED.DE income_statement (annual, 2023-12-31) — Net Interest Income: -21410632.00
MED.DE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -42144.00
MED.DE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -21410632.00
MED.DE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1606186.00
MED.DE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 18989393.00
MED.DE balance_sheet (annual, 2023-12-31) — Net PPE: 514377000.00
MED.DE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -33949026.00
MED.DE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 173117849.00
MED.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 11029692.00